Benzodiazepines were the world’s top prescriptions by 1977
Leo Sternbach stumbled onto chlordiazepoxide in 1955; Librium arrived in 1960 and Valium followed in 1963. They calm by boosting GABA at GABAA receptors—useful for a few weeks, and far more contentious when prescriptions stretch into years.
Benzodiazepines are CNS depressants built on fused benzene and diazepine rings, nicknamed benzos. Leo Sternbach discovered the first, chlordiazepoxide (Librium), accidentally in 1955; Hoffmann–La Roche marketed it in 1960 and followed with diazepam (Valium) in 1963. By 1977 they were the most prescribed medicines on Earth, though SSRIs and other shifts later slowed that dominance. Enhancing GABA at GABAA receptors yields sedation, sleep induction, anxiety relief, seizure control, and muscle relaxation; high doses of many short-acting agents can also cause anterograde amnesia and dissociation. Clinicians use them for severe anxiety, panic, insomnia, agitation, seizures, spasms, alcohol withdrawal, and procedural premedication, sorting agents into short-, intermediate-, and long-acting classes.
Short-term use of about two to four weeks is generally viewed as safe and effective, yet cognitive blunting and paradoxical aggression or disinhibition can appear. Victoria’s health department warns that long-term use may bring impaired thinking, memory loss, anxiety, depression, irritability, paranoia, or aggression. Dependence, withdrawal, fading benefit, and debated links to dementia and cancer make prolonged courses controversial; older adults face higher short- and long-term risks, so all benzodiazepines appear on the Beers List of inappropriate geriatric drugs. Pregnancy safety is unsettled: they are not major teratogens, but a possible small cleft-palate signal remains uncertain. Suicide risk rises via aggression, impulsivity, and harsh withdrawal.
Overdose alone seldom kills—benzodiazepines are less toxic than barbiturates—but mixing with alcohol or opioids sharply raises fatal risk. Flumazenil can reverse overdose in controlled settings yet risks seizures outside them. Recreational use and polydrug combinations are common, and most countries control the class. Expert bodies still disagree on long-term panic treatment: some reserve benzos for resistant cases; others see lasting efficacy comparable to SSRIs. APA 2009 guidance backed them strongly for initial panic care while stressing individualized choice among drugs and psychotherapy. The molecules that quiet GABA also demand an exit plan.
Source: Benzodiazepine
